Population  of  Interest

  • Patients resuscitated with blood products in deployed Role 3 Military Treatment Facilities.

Intent

  • TSWB is only used when the recipient’s blood type is confirmed and identical TSWB is available
  • LTOWB or appropriate component therapy featuring universal donor products is used when TSWB is not appropriate
  • WBB is activated when indicated by senior surgeon
  • Proper documentation is completed for each unit transfused.
  • Any transfusion reaction is appropriately documented.

Performance/Adherence  Metrics

  • TSWB is used when blood type of the recipient has been confirmed by a laboratory
  • LTOWB is used when the recipient’s blood type is unknown or not confirmed by a laboratory.
  • Type A whole blood is used at the Role 3 MTF for Type A recipients when appropriate pretransfusion testing has been completed.
  • Frequency of hemolytic transfusion reactions due to blood typing error or clerical error is documented and reported as a CCIR.
  • Documentation of all blood products transfused to include time of transfusion.

Data  Source

  • Blood transfusion databases
  • DoD Trauma Registry
  • Patient Record